Ares-backed LaserAway weighs sale in deal that could exceed $2bn
LaserAway, a US medspa and aesthetic dermatology operator backed by Ares Management and Seidler Equity Partners, is exploring a potential sale that could value the business at more than $2bn, according to a report by Reuters citing unnamed people familiar with the situation.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.